JPMorgan Chase & Co’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-79
| Closed | – | – | 6466 |
|
|
2023
Q1 | $0 | Hold |
79
| – | – | ﹤0.01% | 6292 |
|
|
2022
Q4 | $0 | Sell |
79
-1,299
| -94% | – | ﹤0.01% | 6153 |
|
|
2022
Q3 | $1K | Buy |
1,378
+509
| +59% | +$369 | ﹤0.01% | 5483 |
|
|
2022
Q2 | $3K | Sell |
869
-9,207
| -91% | -$31.8K | ﹤0.01% | 5394 |
|
|
2022
Q1 | $63K | Buy |
10,076
+2,254
| +29% | +$14.1K | ﹤0.01% | 4930 |
|
|
2021
Q4 | $87K | Sell |
7,822
-2,476
| -24% | -$27.5K | ﹤0.01% | 4886 |
|
|
2021
Q3 | $168K | Buy |
10,298
+4,270
| +71% | +$69.7K | ﹤0.01% | 4494 |
|
|
2021
Q2 | $112K | Sell |
6,028
-22,513
| -79% | -$418K | ﹤0.01% | 4732 |
|
|
2021
Q1 | $430K | Buy |
28,541
+13,383
| +88% | +$202K | ﹤0.01% | 4122 |
|
|
2020
Q4 | $489K | Buy |
+15,158
| New | +$489K | ﹤0.01% | 3761 |
|